| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/22/2010 | WO2009138847A3 An improved process for the preparation of cefozopran |
| 04/22/2010 | WO2009129491A4 Beta adrenergic receptor agonists for treatment of pain and/or inflammation |
| 04/22/2010 | WO2009128918A8 Combination therapy using a soluble hyaluronidase and a bisphosphonate |
| 04/22/2010 | WO2009087690A3 Multiparticulate extended release pharmaceutical composition of carbamazepine and process for manufacturing the same |
| 04/22/2010 | WO2009034558A3 Rhein or diacerein compositions |
| 04/22/2010 | WO2008047241A3 Modified corticotropin releasing factor peptides and uses thereof |
| 04/22/2010 | US20100100181 Devices, systems and methods for diagnosing and treating sinusitus andother disorders of the ears, nose and/or throat |
| 04/22/2010 | US20100100030 Microbe Reductions with Photosensitizers |
| 04/22/2010 | US20100099771 Use of cooling agents to relieve mild ocular irritation and enhance comfort |
| 04/22/2010 | US20100099723 Bioavailable compositions of metaxalone and processes for producing the same |
| 04/22/2010 | US20100099655 Implants and methods for treating inflammation-mediated conditions of the eye |
| 04/22/2010 | US20100099653 Particle Size Reduction Apparatus, and Use Thereof |
| 04/22/2010 | US20100099636 Hydrous gel and production process and use of the hydrous gel |
| 04/22/2010 | US20100099629 Ophthalmological composition |
| 04/22/2010 | US20100099625 Bio-security system |
| 04/22/2010 | US20100099621 Disodium salts, monohydrates, and ethanol solvates for delivering active agents |
| 04/22/2010 | US20100099566 Agriculture actives delivery composition comprising boron and persulfate ion-crosslinked polyvinyl alcohol microcapsules and method of use thereof |
| 04/22/2010 | US20100098773 Polymer vesicles for selective electromagnetic energy-induced delivery |
| 04/22/2010 | US20100098772 Drug delivery systems and methods for treating neovascularization |
| 04/22/2010 | US20100098771 Abuse-resistant oral dosage forms and method of use thereof |
| 04/22/2010 | US20100098770 Sirolimus pharmaceutical formulations |
| 04/22/2010 | US20100098769 Synthetic Peptides Reducing or Removing Bags Formed Under the Lower Eye Contour and Their Use in Cosmetic or Dermopharmaceutical Compositions |
| 04/22/2010 | US20100098768 Method of neuroprotection from oxidant injury using metal oxide nanoparticles |
| 04/22/2010 | US20100098767 Convection enhanced delivery apparatus, method, and application |
| 04/22/2010 | US20100098766 Use of an aqueous micro-emulsion for the preparation of a formulation for the treatment of adipose diseases |
| 04/22/2010 | US20100098765 Powder Makeup Compositions And Methods |
| 04/22/2010 | US20100098764 Polysaccharide gel formulation having multi-stage bioactive agent delivery |
| 04/22/2010 | US20100098763 Pharmaceutical formulation 514 |
| 04/22/2010 | US20100098762 Thermosensitive Pluronic Derivative Hydrogels With High Biodegradability And Biocompatibility For Tissue Regeneration And Preparation Method Thereof |
| 04/22/2010 | US20100098761 Polymer Compositions For Biomedical And Material Applications |
| 04/22/2010 | US20100098759 Controlled-release preparation containing cilostazol and process for the preparation thereof |
| 04/22/2010 | US20100098758 Abuse-Resistant Dosage Form |
| 04/22/2010 | US20100098757 Process for production of buprenorphine pharmaceutical preparation to be applied to mouth mucosa |
| 04/22/2010 | US20100098756 Oral disintegrating tablet |
| 04/22/2010 | US20100098755 Process of producing directly compressed tablets of sterols and/or stanols |
| 04/22/2010 | US20100098754 Processing of heat-sensitive active agents |
| 04/22/2010 | US20100098753 Prophylactic and/or therapeutic agent for cardiac infarction |
| 04/22/2010 | US20100098752 Materials and Methods for Delivering Antioxidants into the Skin |
| 04/22/2010 | US20100098750 Pharmaceutical composition comprising phenylamidine derivative and method of using the pharmaceutical composition in combination with antifungal agent |
| 04/22/2010 | US20100098749 Methods for joint lubrication and cartilage wear prevention making use of glycerophospholipids |
| 04/22/2010 | US20100098748 Arg-Gly-Asp (RGD) Sequence Containing Cyclic Peptide and Its Active Targeting Liposomes |
| 04/22/2010 | US20100098747 Percutaneous administration device of bisoprolol |
| 04/22/2010 | US20100098745 Methods for delivery of medication using dissolvable devices |
| 04/22/2010 | US20100098743 Medical substitute membrane, use thereof, and method for repair of membrane tissue in living body |
| 04/22/2010 | US20100098742 Fabrication of tissue lamina using microfabricated two-dimensional molds |
| 04/22/2010 | US20100098740 Method of controlling a drug release rate |
| 04/22/2010 | US20100098736 Connective tissue repair |
| 04/22/2010 | US20100098735 Injectable depot compositions and its process of preparation |
| 04/22/2010 | US20100098734 Methods for preparation of a thixotropic microemulsion for skin care formulations |
| 04/22/2010 | US20100098733 Nitric oxide releasing particles for oral care applications |
| 04/22/2010 | US20100098731 Hollow sphere from amphiphilic chitosan derivatives and method of preparing amiphiphilic chitosan derivative complex for medical use |
| 04/22/2010 | US20100098656 Polyamino acids functionalized by hydrophobic grafts bearing an anionic charge and applications thereof, such as therapeutic applications |
| 04/22/2010 | US20100098642 Optimised formulation of tobramycin for aerosolization |
| 04/22/2010 | US20100098641 Monophosphates as Mutual Prodrugs of Anti-Inflammatory Signal Transduction Modulators (AISTM's) and Beta-Agonists for the Treatment of Pulmonary Inflammation and Bronchoconstriction |
| 04/22/2010 | US20100098639 Compositions and Methods for Convection Enhanced Delivery of High Molecular Weight Neurotherapeutics |
| 04/22/2010 | US20100095963 Pharmaceutical compositions |
| 04/22/2010 | DE202004021680U1 Feste pharmazeutische Zusammensetzung A solid pharmaceutical composition |
| 04/22/2010 | DE102008051783A1 Valsartan enthaltende Tablette Valsartan containing tablet |
| 04/22/2010 | DE102008042923A1 Präparate zur gesteuerten Freisetzung von Wirkstoffen Preparations for the controlled release of active ingredients |
| 04/22/2010 | CA2822167A1 Pharmaceutical topical compositions |
| 04/22/2010 | CA2805888A1 Whey protein compostions, methods and uses |
| 04/22/2010 | CA2740762A1 Method of protecting cells |
| 04/22/2010 | CA2740418A1 Salicylic acid composition |
| 04/22/2010 | CA2740360A1 Method for treatment of copd and other pulmonary diseases |
| 04/22/2010 | CA2739954A1 Methods of treating pulmonary disorders with liposomal amikacin formulations |
| 04/22/2010 | CA2739046A1 Processes and compositions for liposomal and efficient delivery of gene silencing therapeutics |
| 04/22/2010 | CA2738715A1 Highly concentrated drug particles, formulations, suspensions and uses thereof |
| 04/22/2010 | CA2738614A1 Drop pill for treating coronary heart disease and preparation thereof |
| 04/22/2010 | CA2738384A1 Pharmaceutical topical compositions |
| 04/22/2010 | CA2737307A1 Multi portion intra-oral dosage form and use thereof |
| 04/22/2010 | CA2641541A1 Methods for inducing programmed cell death |
| 04/21/2010 | EP2177531A2 Cell permeable peptide |
| 04/21/2010 | EP2177230A1 Immunoliposome inducing apoptosis into cell expressing death domain-containing receptor |
| 04/21/2010 | EP2177220A1 Gel containing pirfenidone |
| 04/21/2010 | EP2177217A1 Composition comprising rotigotine, its use and transdermal patch comprising the composition |
| 04/21/2010 | EP2177214A1 Solid Oral Dosage Forms and Uses |
| 04/21/2010 | EP2177213A1 Nicotine-containing granulate |
| 04/21/2010 | EP2177212A1 Methods of using lamellar bodies for therapeutic purposes |
| 04/21/2010 | EP2177211A1 Organic-inorganic hybrid material for storage and release of active principles |
| 04/21/2010 | EP2177210A1 Method of producing microparticles to be ingested into the body, microparticles to be ingested into the body and dispersion and medicinal composition containing the same |
| 04/21/2010 | EP2177209A1 Intravenous solutions and uses |
| 04/21/2010 | EP2177208A1 Pharmaceutical topical compositions |
| 04/21/2010 | EP2177201A1 Oil-in-water emulsion composition and method for producing the same |
| 04/21/2010 | EP2176357A2 A colouring composition comprising starch derivatives as a hydrocolloid |
| 04/21/2010 | EP2175922A2 Delivery systems for delivering functional compounds to substrates and processes of using the same |
| 04/21/2010 | EP2175887A1 Compositions for delivery of therapeutics and other materials |
| 04/21/2010 | EP2175881A1 Intradermal influenza vaccine |
| 04/21/2010 | EP2175865A2 Controlled release interferon drug products and treatment of hcv infection using same |
| 04/21/2010 | EP2175855A1 Stable pharmaceutical composition of a water-soluble vinorelbine salt |
| 04/21/2010 | EP2175843A2 Extended release compositions comprising tolterodine |
| 04/21/2010 | EP2175841A1 Osteopontin nanoparticles system for drug delivery |
| 04/21/2010 | EP2175840A2 Pharmaceutical compositions comprising ropinirole |
| 04/21/2010 | EP2175839A1 Controlled release pharmaceutical composition of tolperison hydrochloride |
| 04/21/2010 | EP2175838A2 An inhalable medicament |
| 04/21/2010 | EP2175837A2 Micro-particles, blood-substitute and method for forming same |
| 04/21/2010 | EP2175836A2 Liposome composition |
| 04/21/2010 | EP2175835A1 Methods for generating immune response using cationic-liposome-mediated nucleic acid delivery |
| 04/21/2010 | EP2175834A2 Glp-1-fc fusion protein formulation |
| 04/21/2010 | EP2175828A2 A composition to impart benefit agents to anionic substrates and methods of its use |
| 04/21/2010 | EP2175742A1 Use of cordyceps species or extract thereof in the egg production |